SORRENTO THERAPEUTICS INC (SRNE) Stock Analyst Ratings
NASDAQ:SRNE - Nasdaq - US83587F2020 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to SRNE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.82. This target is 2444.76% above the current price.
SRNE was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SRNE.
In the previous month the buy percentage consensus was at a similar level.
SRNE was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-08-09 | HC Wainwright & Co. | Maintains | Buy |